SynthesisFrontiers in pharmacology2020

Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis.

Yi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.